• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in.

作者信息

Goede V, Fischer K, Busch R, Jaeger U, Dilhuydy M-S, Wickham N, De Guibert S, Ritgen M, Langerak A W, Bieska G, Engelke A, Humphrey K, Wenger M, Hallek M

出版信息

Leukemia. 2013 Apr;27(5):1172-4. doi: 10.1038/leu.2012.252. Epub 2012 Aug 31.

DOI:10.1038/leu.2012.252
PMID:22936013
Abstract
摘要

相似文献

1
Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in.GA101联合苯丁酸氮芥用于慢性淋巴细胞白血病合并症患者的化学免疫疗法：CLL11（BO21004）安全性导入试验结果
Leukemia. 2013 Apr;27(5):1172-4. doi: 10.1038/leu.2012.252. Epub 2012 Aug 31.
2
Profuse erythema multiforme induced by chlorambucil.苯丁酸氮芥诱发的重症多形红斑。
Ann Hematol. 2007 Jul;86(7):539-40. doi: 10.1007/s00277-007-0273-y. Epub 2007 Feb 27.
3
Pregnancy in chronic lymphocytic leukemia: experience with fetal exposure to chlorambucil.慢性淋巴细胞白血病患者的妊娠：胎儿暴露于苯丁酸氮芥的经验。
Leuk Res. 2009 Apr;33(4):567-9. doi: 10.1016/j.leukres.2008.05.019. Epub 2008 Jul 7.
4
Extensive exfoliative dermatitis induced by chlorambucil.苯丁酸氮芥诱发的广泛性剥脱性皮炎。
Am J Hematol. 2006 Nov;81(11):891-2. doi: 10.1002/ajh.20612.
5
Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia.一名慢性淋巴细胞白血病患者对苯丁酸氮芥出现严重皮肤不良反应。
Anticancer Drugs. 1997 Jun;8(5):468-9. doi: 10.1097/00001813-199706000-00009.
6
[First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment].老年慢性淋巴细胞白血病的一线治疗：谨防过度治疗
Presse Med. 2009 Jan;38(1):140-2. doi: 10.1016/j.lpm.2008.10.004. Epub 2008 Nov 11.
7
Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.苯丁酸氮芥治疗慢性淋巴细胞白血病后发生肿瘤溶解综合征：病例报告及文献复习
Tenn Med. 2009 Oct;102(10):33-6.
8
Chlorambucil-induced inappropriate antidiuresis in a man with chronic lymphocytic leukemia.苯丁酸氮芥诱导一名慢性淋巴细胞白血病男性出现抗利尿激素分泌失调综合征。
Ann Hematol. 1999 Jan;78(1):37-8. doi: 10.1007/s002770050470.
9
Systemic delayed hypersensitivity reaction to chlorambucil: a case report and literature review.苯丁酸氮芥引起的全身性迟发型超敏反应：一例报告及文献综述
Contact Dermatitis. 2018 Feb;78(2):171-173. doi: 10.1111/cod.12883.
10
High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.高剂量苯丁酸氮芥对比比内改良的环磷酰胺、阿霉素、长春新碱及泼尼松方案治疗晚期B细胞慢性淋巴细胞白血病。一项国际多中心随机试验的结果。维也纳化学免疫治疗国际协会
Cancer. 1997 Jun 1;79(11):2107-14.

引用本文的文献

1
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.慢性淋巴细胞白血病：2025年流行病学、发病机制、诊断与治疗最新进展
Am J Hematol. 2025 Mar;100(3):450-480. doi: 10.1002/ajh.27546. Epub 2025 Jan 28.
2
Multisystem Inflammatory Syndrome: A Case in an Adult With Controlled Lymphoma and a Persistent SARS-CoV-2 Infection.多系统炎症综合征：一例患有可控性淋巴瘤且持续感染严重急性呼吸综合征冠状病毒2的成年病例。
Cureus. 2023 Jun 22;15(6):e40776. doi: 10.7759/cureus.40776. eCollection 2023 Jun.
3
miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study.
初诊时的 miRNA 谱可预测 B 慢性淋巴细胞白血病患者的治疗结局：一项 FILO 研究。
Front Immunol. 2022 Oct 17;13:983771. doi: 10.3389/fimmu.2022.983771. eCollection 2022.
4
SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients.SIRPα 通过慢性淋巴细胞白血病患者的类护士细胞抑制对治疗性抗体的反应。
Front Immunol. 2021 Jan 21;11:610523. doi: 10.3389/fimmu.2020.610523. eCollection 2020.
5
Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study.奥滨尤妥珠单抗联合氟达拉滨和环磷酰胺治疗初治、身体状况良好的慢性淋巴细胞白血病患者：GREEN 研究的亚组分析。
Leukemia. 2020 Feb;34(2):441-450. doi: 10.1038/s41375-019-0554-1. Epub 2019 Aug 27.
6
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.苯丁酸氮芥靶向 BRCA1/2 缺陷型肿瘤并克服 PARP 抑制剂耐药性。
EMBO Mol Med. 2019 Jul;11(7):e9982. doi: 10.15252/emmm.201809982. Epub 2019 May 24.
7
Anti-CD20 monoclonal antibodies: reviewing a revolution.抗CD20单克隆抗体：回顾一场变革。
Hum Vaccin Immunother. 2018;14(12):2820-2841. doi: 10.1080/21645515.2018.1508624. Epub 2018 Sep 6.
8
Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study.在 IIIb 期 GREEN 研究中，奥滨尤妥珠单抗单药或联合化疗治疗未经治疗或复发/难治性慢性淋巴细胞白血病的安全性。
Haematologica. 2018 Nov;103(11):1889-1898. doi: 10.3324/haematol.2017.186387. Epub 2018 Jul 5.
9
Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy.奥滨尤妥珠单抗治疗慢性淋巴细胞白血病：设计、研发及治疗地位
Drug Des Devel Ther. 2017 Jan 25;11:295-304. doi: 10.2147/DDDT.S104869. eCollection 2017.
10
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies.新型II型抗CD20单克隆抗体奥滨尤妥珠单抗（GA101）治疗B细胞恶性肿瘤患者的综述
Adv Ther. 2017 Feb;34(2):324-356. doi: 10.1007/s12325-016-0451-1. Epub 2016 Dec 21.